SEC Form 4 · accession 0001127602-15-031150
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — EVP & Chief Operating Officer
Period of report
Nov 10, 2015
Accepted (ET)
Nov 12, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2015 | M | 2,000 | $61.06 | A | 3,375 | D | |
| Common Stock | Nov 10, 2015 | D | 2,000 | $156.75 | D | 1,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $61.06 | Nov 10, 2015 | M | 2,000 | D | Mar 15, 2014 | Mar 15, 2023 | Common Stock | 2,000 | 25,000 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.